Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:2435-2446, doi:10.1016/j.jacc.2009.08.031
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buss, S. J.
Right arrow Articles by Hardt, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buss, S. J.
Right arrow Articles by Hardt, S. E.
Related Collections
Right arrowRelated Article

Beneficial Effects of Mammalian Target of Rapamycin Inhibition on Left Ventricular Remodeling After Myocardial Infarction

Sebastian J. Buss, MD*, Sebastian Muenz, MD*, Johannes H. Riffel, MD*, Pratima Malekar, PhD*, Marco Hagenmueller, PhD*, Celine S. Weiss, MD*, Florian Bea, MD*, Raffi Bekeredjian, MD*, Martina Schinke-Braun, PhD{dagger}, Seigo Izumo, MD, PhD{dagger}, Hugo A. Katus, MD* and Stefan E. Hardt, MD*,*

* Department of Cardiology, University of Heidelberg, Heidelberg, Germany
{dagger} Novartis Institutes of Biomedical Research, Cardiovascular Research, Cambridge, Massachusetts


Figure 1
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 mTOR Inhibition Attenuates Myocardial Remodeling After MI

(A) Transthoracic echocardiographic M-Mode images recorded from the parasternal short axis on the level of the papillary muscles of the left ventricle (LV) in sham-, vehicle-, and everolimus (RAD)-treated (3.0 mg/kg/day) animals after 28 days. (B) Ejection fraction (EF) was significantly higher in the RAD-treatment group after 28 days as compared with vehicle. (C) End-diastolic diameter (EDD) and (D) end-systolic diameter (ESD) of the LV estimated from transthoracic echocardiographic M-Mode images. The EDD and ESD were significantly reduced in RAD-treated animals (3.0 mg/kg/day) after 28 days. *p < 0.05 versus sham; #p < 0.05 versus vehicle. Sham n = 6, vehicle n = 14, RAD n = 14. MI = myocardial infarction; mTOR = mammalian target of rapamycin.

 

Figure 2
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Representative Pressure-Volume Loops During Steady-State Conditions in Sham-, Vehicle-, and RAD-Treated Rats 28 Days After MI

A significant rightward shift of the pressure volume loops is observed in the vehicle-treated animals, which can be reduced ("leftwarded") by treatment with RAD 3.0 mg/kg/day. RVU = relative volume unit; other abbreviations as in Figure 1.

 

Figure 3
View larger version (43K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Effects of RAD Treatment on Infarct Size and Myocardial Hypertrophy

(A) Quantitative measurement of infarct size by triphenyl tetrazolium chloride (TTC) staining. Infarct size was significantly smaller in RAD-treated animals as compared with vehicle-treated animals 28 days after MI. (B) Representative examples of Masson's trichrome staining of infarcted hearts. Smaller infarct size was confirmed by histology in the RAD-treatment group. (C) The increased ratio of heart weight (HW) to tibia length (TL) in vehicle-treated MI-animals was significantly reduced after RAD treatment. *p < 0.05 versus sham; #p < 0.05 versus vehicle. Abbreviations as in Figure 1.

 

Figure 4
View larger version (50K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Effects of RAD Treatment on Cardiac Myocyte Size and ANF Expression

(A) Exemplary hematoxylin eosin stainings of a section of the remote area of the MI in sham, vehicle, and RAD-treated animals after 28 days. (B) Quantitative measurement of the myocyte size 28 days after MI. Myocyte size was significantly smaller in RAD-treated animals as compared with vehicle-treated animals. Sham n = 5, vehicle n = 5, RAD n = 13. (C) Gene expression of atrial natriuretic factor (ANF) normalized to the house-keeping gene HPRT was significantly increased in vehicle MI-animals but not in the RAD-treatment group. *p < 0.05 versus sham; #p < 0.05 versus vehicle. Abbreviations as in Figure 1.

 

Figure 5
View larger version (47K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Protein Levels and Phosphorylation Levels of mTOR-Related Regulators of Protein Synthesis

(A) Western blot analysis revealed a significant decrease of phosphorylation of 4E-BP1 (Thr 70) after administration of RAD after MI. (B) Protein levels of phospho-p70/S6K after MI; p70/S6K, 1 of the main downstream targets of mTOR—which mediates cellular growth—displayed a significant decrease of phosphorylation after administration of RAD after MI. (C) Phospho ribosomal S6K is significantly reduced by mTOR-inhibition. Coomassie blue staining confirms similar loading of protein. Veh = vehicle; other abbreviations as in Figure 1.

 

Figure 6
View larger version (48K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Protein Degradation Mechanisms Are Regulated by mTOR After MI

(A) LC3, a marker of autophagy, is up-regulated in the border zone 3 days after MI in RAD-treated animals. (B and C) Detection of autophagosomes in vivo by monodansylcadaverine (MDC) 3 days after MI in vehicle (Veh)- and RAD-treated animals (B). Activity of LC3 corresponded to autophagous flux assessed by MDC (C). (D and E) Concomitant down-regulation of the ubiquitin proteasome system is observed. (F) Electrophoretic mobility shift assay blot for nuclear factor-kappa B (NF{kappa}B), demonstrating a reduced activity in MI animals after RAD-treatment. (G) Densitometric quantification of NF{kappa}B clearly demonstrates the significant reduction of NF{kappa}B in the border zone of the infarction. (H) Western blot of the p65 subunit also showed significant reduction due to treatment with RAD. (I) In the border zone of the infarction, a reduced macrophage invasion was observed. #p < 0.05 versus Veh. Cq = chloroquine; RFU = relative fluorescence units; other abbreviations as in Figure 1.

 

Figure 7
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7 Morphology and Echocardiography After Initiation of RAD Treatment 3 Days After MI

(A) The increased HW/TL ratio in vehicle-treated MI-animals was significantly reduced after RAD treatment (3.0 mg/kg/day) starting 3 days after infarction. (B) Quantitative measurement of the myocyte size 28 days after MI. Myocyte size was significantly smaller in RAD-treated animals as compared with vehicle-treated animals. (C to E) Transthoracic echocardiography. (C) The EF was significantly higher in the RAD-treatment group after 28 days as compared with vehicle. (D and E) The EDD and ESD of the LV showed a significant reduction due to RAD treatment compared with vehicle. #p < 0.05 versus vehicle. Abbreviations as in Figures 1 and 3.

 

Figure 8
View larger version (29K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 8 Autophagy and NF{kappa}B Activation 28 Days After MI With RAD Treatment Starting 1 or 3 Days After MI

(A) LC3, a marker of autophagy, is still up-regulated in the remote area 28 days after MI in RAD-treated animals after 1 and 3 days (3.0 mg/kg/day). (B) The concomitant down-regulation of the ubiquitin proteasome system is still observed. (C and D) Electrophoretic mobility shift assay blot demonstrating reduced activation of NF{kappa}B in MI animals with RAD treatment initiated 3 days after MI in the remote area of the myocardium. Densitometric quantification is shown in D. #p < 0.05 versus vehicle. Abbreviations as in Figures 1 and 6.

 

Figure 9
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 9 Long-Term Effects of RAD Treatment

The RAD treatment (starting on day 1 after MI) for 28 days led to sustained improvement of LV function 3 months after MI (squares, solid lines), whereas vehicle-treated animals display a progressive deterioration of LV ejection fraction (triangles, dashed lines). Data from serial echocardiography in the same animals are depicted. #p < 0.05 versus vehicle. Abbreviations as in Figure 1.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement